News

Excluding employer-provided care from drug pricing reform is raising concern among both progressive and employer organizations.

The case concluded with total distributions of $68 million to more than 200 employee benefit plans harmed by John Koresko and associates.

Meanwhile, the share of people who are employed or looking for work didn't change, restrained by persistent child-care challenges and virus concerns.

Hospitals and providers have raised concerns about how purchase strategies affect the quality, effectiveness, and safety of specialty medications.

NAIC is setting up a working group that will look at marketing of products that do not meet ACA requirements for major medical insurance.

The bill is expected to extend payroll taxes to high earners and change the way COLAs are calculated.